Heartseed Inc. is pleased to announce that it has been awarded "Emerging Biotech Company" at the "BioSpectrum Asia Excellence Awards 2026," hosted by BioSpectrum Asia, a leading life sciences media platform in the Asia-Pacific (APAC) region.

This award is highly regarded across the APAC biotechnology and life sciences industries as one of the most prestigious business accolades, known for its high visibility and credibility.
 

■ Background and Selection Criteria

Winners of the "BioSpectrum Asia Excellence Awards" are selected through a rigorous evaluation process conducted by an independent panel of judges　-comprising distinguished scientists and industry executives- alongside market research.

This award recognizes Heartseed's clinical achievements in cardiomyocyte replacement therapy using its proprietary "iPS cell-derived cardiomyocyte spheroids," its strong competitive advantages, as well as the technological innovation and future growth potential offered in both Asian and global markets.

■ Comment from Keiichi Fukuda, CEO of Heartseed Inc.

"We are deeply honored to receive this award at the 'BioSpectrum Asia Excellence Awards 2026,' a highly influential event in the APAC life sciences industry. We believe this recognition is a testament to the international acclaim for our technology and the innovative nature of our cardiomyocyte replacement therapy. We remain committed to accelerating our R&D and business operations to deliver this novel therapeutic option to patients suffering from severe heart failure worldwide as quickly as possible."

■ Award Summary

• Award Title: BioSpectrum Asia Excellence Awards 2026
• Award Category: Emerging Biotech Company
• Organizer: BioSpectrum Asia (Parent Company: MM Activ Sci-Tech Communications)
• Official Announcement:
  https://www.biospectrumasia.com/news/115/28472/biospectrum-asia-announces-the-winners-of-its-2026-excellence-awards.html
  
  

■ About BioSpectrum Asia

BioSpectrum Asia is one of the largest business media and information platforms comprehensively covering the life sciences, biopharmaceuticals, medical devices, and pharmaceutical industries across the Asia-Pacific region. The award ceremony is scheduled to take place in Singapore on December 4, 2026, bringing together government officials, academic leaders, and top industry executives from across the APAC region.